Correlation Engine 2.0
Clear Search sequence regions


  • drug carrier (3)
  • help (1)
  • indomethacin (5)
  • signal (2)
  • Sizes of these terms reflect their relevance to your search.

    Challenges associated with topical analgesics and anti-inflammatory drugs include poor drug penetration and retention at the desired lesion site. Therefore, improving these challenges would help to reduce the toxic and side effects caused by drug absorption into the systemic circulation and improve the therapeutic efficacy of topical therapeutic drugs. Pentapeptide (KTTKS) is a signal peptide in skin tissue, it can be recognized and bound by signal recognition particles. In the current study, we successfully prepared novel indomethacin (IMC) loaded KTTKS-modified ethosomes (IMC-KTTKS-Es), and the physicochemical properties and topical efficacy were investigated. Results showed that the prepared IMC-KTTKS-Es displayed a particle size of about 244 nm, a negative charge, good deformability, and encapsulation efficiency (EE) exceeding 80% for IMC, with a sustained release pattern. In vitro percutaneous permeation studies revealed that the skin retention was increased after the drug was loaded in the IMC-KTTKS-Es. Confocal laser scanning microscopy also showed improved skin retention of IMC-KTTKS-Es. In addition, IMC-KTTKS-Es showed improved topical analgesic and anti-inflammatory activity with no potentially hazardous skin irritation. This study suggested that the IMC-KTTKS-Es might be an effective drug carrier for topical skin therapy with a good safety profile.

    Citation

    Jiangxiu Niu, Ming Yuan, Hongying Li, Yao Liu, Liye Wang, Yanli Fan, Yansong Zhang, Xianghui Liu, Lingmei Li, Jingxiao Zhang, Chenyu Zhao. Pentapeptide modified ethosomes for enhanced skin retention and topical efficacy activity of indomethacin. Drug delivery. 2022 Dec;29(1):1800-1810

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35656937

    View Full Text